Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LLY | JNJ | ABBV | ||
| Company | Eli Lilly and Company | Johnson & Johnson | Abbvie Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 1,019.17 | 244.03 | 225.10 | ||
| High | 1,053.00 | 248.94 | 232.27 | ||
| Low | 1,017.36 | 242.50 | 225.06 | ||
| Latest | 1,051.99 | 248.43 | 232.08 | ||
| Change | +29.97 | +4.96 | +7.39 | ||
| % Change | +2.93% | +2.04% | +3.29% | ||
| Volume | 4,325,900 | 16,428,500 | 8,018,000 | ||
| 20-Day Average Volume | 3,790,380 | 9,615,555 | 7,220,035 | ||
| Previous Close | 1,022.02 | 243.47 | 224.69 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1,036.35 | 240.81 | 225.59 | ||
| 20-Day Raw Stochastic | 48.51% | 97.84% | 89.77% | ||
| 20-Day Relative Strength | 51.84 | 72.64 | 56.34 | ||
| Weighted Alpha | +25.71 | +62.76 | +15.02 | ||
| Today's Opinion | 64% Buy | 100% Buy | 72% Buy | ||
| Previous Opinion | 48% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.21% since 02/20/26 | +2.45% since 02/20/26 | +3.23% since 02/20/26 | ||
| Low | 1,007.38 on 02/26/26 | 242.02 on 02/26/26 | 221.13 on 02/26/26 | ||
| High | 1,064.45 on 02/23/26 | 248.94 on 02/27/26 | 232.55 on 02/25/26 | ||
| 1-Month | |||||
| %Chg | +1.20% since 01/27/26 | +10.69% since 01/27/26 | +3.64% since 01/27/26 | ||
| Low | 993.58 on 02/03/26 | 225.33 on 01/30/26 | 204.27 on 02/04/26 | ||
| High | 1,114.00 on 02/04/26 | 248.94 on 02/27/26 | 235.25 on 02/17/26 | ||
| 3-Month | |||||
| %Chg | -4.74% since 11/26/25 | +19.69% since 11/26/25 | +1.94% since 11/26/25 | ||
| Low | 977.12 on 12/10/25 | 199.90 on 12/09/25 | 204.27 on 02/04/26 | ||
| High | 1,133.95 on 01/08/26 | 248.94 on 02/27/26 | 237.04 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +43.29% since 08/27/25 | +40.52% since 08/27/25 | +11.54% since 08/27/25 | ||
| Low | 712.05 on 09/25/25 | 173.33 on 09/19/25 | 204.27 on 02/04/26 | ||
| High | 1,133.95 on 01/08/26 | 248.94 on 02/27/26 | 244.81 on 10/01/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 992,402,048 | 598,691,136 | 410,356,640 | ||
| Shares Outstanding, K | 943,357 | 2,409,899 | 1,768,169 | ||
| Annual Sales | 65,179,000,000 | 94,193,000,000 | 61,160,000,000 | ||
| Annual Net Income | 20,640,000,000 | 26,804,000,000 | 4,226,000,000 | ||
| Last Quarter Sales | 19,292,000,000 | 24,564,000,000 | 16,618,000,000 | ||
| Last Quarter Net Income | 6,637,700,000 | 5,116,000,000 | 1,816,000,000 | ||
| 60-Month Beta | 0.39 | 0.35 | 0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 7.54 on 02/04/26 | 2.46 on 01/21/26 | 2.71 on 02/04/26 | ||
| Latest Earnings Date | 05/07/26 | 04/21/26 | 04/24/26 | ||
| Most Recent Dividend | 1.730 on 02/13/26 | 1.300 on 02/24/26 | 1.730 on 01/16/26 | ||
| Next Ex-Dividends Date | 02/13/26 | 02/24/26 | 04/15/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 42.21 | 22.54 | 22.47 | ||